UniProt ID | ACOC_HUMAN | |
---|---|---|
UniProt AC | P21399 | |
Protein Name | Cytoplasmic aconitate hydratase | |
Gene Name | ACO1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 889 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Iron sensor. Binds a 4Fe-4S cluster and functions as aconitase when cellular iron levels are high. Functions as mRNA binding protein that regulates uptake, sequestration and utilization of iron when cellular iron levels are low. Binds to iron-responsive elements (IRES) in target mRNA species when iron levels are low. Binding of a 4Fe-4S cluster precludes RNA binding.; Catalyzes the isomerization of citrate to isocitrate via cis-aconitate.. | |
Protein Sequence | MSNPFAHLAEPLDPVQPGKKFFNLNKLEDSRYGRLPFSIRVLLEAAIRNCDEFLVKKQDIENILHWNVTQHKNIEVPFKPARVILQDFTGVPAVVDFAAMRDAVKKLGGDPEKINPVCPADLVIDHSIQVDFNRRADSLQKNQDLEFERNRERFEFLKWGSQAFHNMRIIPPGSGIIHQVNLEYLARVVFDQDGYYYPDSLVGTDSHTTMIDGLGILGWGVGGIEAEAVMLGQPISMVLPQVIGYRLMGKPHPLVTSTDIVLTITKHLRQVGVVGKFVEFFGPGVAQLSIADRATIANMCPEYGATAAFFPVDEVSITYLVQTGRDEEKLKYIKKYLQAVGMFRDFNDPSQDPDFTQVVELDLKTVVPCCSGPKRPQDKVAVSDMKKDFESCLGAKQGFKGFQVAPEHHNDHKTFIYDNTEFTLAHGSVVIAAITSCTNTSNPSVMLGAGLLAKKAVDAGLNVMPYIKTSLSPGSGVVTYYLQESGVMPYLSQLGFDVVGYGCMTCIGNSGPLPEPVVEAITQGDLVAVGVLSGNRNFEGRVHPNTRANYLASPPLVIAYAIAGTIRIDFEKEPLGVNAKGQQVFLKDIWPTRDEIQAVERQYVIPGMFKEVYQKIETVNESWNALATPSDKLFFWNSKSTYIKSPPFFENLTLDLQPPKSIVDAYVLLNLGDSVTTDHISPAGNIARNSPAARYLTNRGLTPREFNSYGSRRGNDAVMARGTFANIRLLNRFLNKQAPQTIHLPSGEILDVFDAAERYQQAGLPLIVLAGKEYGAGSSRDWAAKGPFLLGIKAVLAESYERIHRSNLVGMGVIPLEYLPGENADALGLTGQERYTIIIPENLKPQMKVQVKLDTGKTFQAVMRFDTDVELTYFLNGGILNYMIRKMAK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSNPFAHLA ------CCCCCHHCC | 53.89 | 28857561 | |
20 | Ubiquitination | DPVQPGKKFFNLNKL CCCCCCCCCCCCCCC | 62.19 | - | |
26 | Ubiquitination | KKFFNLNKLEDSRYG CCCCCCCCCCCCCCC | 57.32 | - | |
30 | Phosphorylation | NLNKLEDSRYGRLPF CCCCCCCCCCCCCCH | 20.30 | 28857561 | |
32 | Phosphorylation | NKLEDSRYGRLPFSI CCCCCCCCCCCCHHH | 15.56 | 24275569 | |
56 | 2-Hydroxyisobutyrylation | NCDEFLVKKQDIENI CCHHHEECHHHHHHH | 47.03 | - | |
57 | Ubiquitination | CDEFLVKKQDIENIL CHHHEECHHHHHHHH | 45.80 | - | |
79 | Ubiquitination | KNIEVPFKPARVILQ CCCCCCCCCCEEEEE | 31.53 | 21890473 | |
105 | Ubiquitination | AAMRDAVKKLGGDPE HHHHHHHHHHCCCHH | 43.96 | 21906983 | |
106 | Ubiquitination | AMRDAVKKLGGDPEK HHHHHHHHHCCCHHH | 45.85 | 21890473 | |
138 | Phosphorylation | DFNRRADSLQKNQDL ECCCCHHHHHHCCCC | 31.54 | 26699800 | |
141 | Acetylation | RRADSLQKNQDLEFE CCHHHHHHCCCCHHH | 62.97 | 23236377 | |
141 | Ubiquitination | RRADSLQKNQDLEFE CCHHHHHHCCCCHHH | 62.97 | 21890473 | |
158 | Ubiquitination | RERFEFLKWGSQAFH HHHHHHHHHCHHHHC | 55.63 | - | |
184 | Phosphorylation | IHQVNLEYLARVVFD EEECCHHHHEEEEEC | 14.61 | - | |
250 | Ubiquitination | IGYRLMGKPHPLVTS HHHHHCCCCCCCCCC | 26.62 | - | |
258 | Phosphorylation | PHPLVTSTDIVLTIT CCCCCCCCHHHHHHH | 22.00 | - | |
289 | Phosphorylation | GPGVAQLSIADRATI CCCCEEEEHHCHHHH | 12.03 | 24719451 | |
318 | Phosphorylation | PVDEVSITYLVQTGR ECCEEEEEEEEECCC | 11.87 | - | |
332 | Phosphorylation | RDEEKLKYIKKYLQA CCHHHHHHHHHHHHH | 28.54 | 26074081 | |
335 | Ubiquitination | EKLKYIKKYLQAVGM HHHHHHHHHHHHHCC | 41.45 | - | |
335 | 2-Hydroxyisobutyrylation | EKLKYIKKYLQAVGM HHHHHHHHHHHHHCC | 41.45 | - | |
336 | Phosphorylation | KLKYIKKYLQAVGMF HHHHHHHHHHHHCCC | 10.07 | 25884760 | |
350 | Phosphorylation | FRDFNDPSQDPDFTQ CCCCCCCCCCCCCCE | 50.51 | 30175587 | |
379 | Acetylation | GPKRPQDKVAVSDMK CCCCCCCCEEHHHHH | 27.18 | 25953088 | |
383 | Phosphorylation | PQDKVAVSDMKKDFE CCCCEEHHHHHHHHH | 23.42 | 22817900 | |
386 | 2-Hydroxyisobutyrylation | KVAVSDMKKDFESCL CEEHHHHHHHHHHHH | 54.93 | - | |
386 | Ubiquitination | KVAVSDMKKDFESCL CEEHHHHHHHHHHHH | 54.93 | 21906983 | |
387 | 2-Hydroxyisobutyrylation | VAVSDMKKDFESCLG EEHHHHHHHHHHHHC | 62.10 | - | |
387 | Ubiquitination | VAVSDMKKDFESCLG EEHHHHHHHHHHHHC | 62.10 | - | |
396 | Ubiquitination | FESCLGAKQGFKGFQ HHHHHCCCCCCCCEE | 49.51 | - | |
400 | Ubiquitination | LGAKQGFKGFQVAPE HCCCCCCCCEEECCC | 66.69 | - | |
455 | Ubiquitination | GAGLLAKKAVDAGLN CHHHHHHHHHHCCCC | 48.30 | - | |
466 | Phosphorylation | AGLNVMPYIKTSLSP CCCCCCCEEECCCCC | 9.28 | 20068231 | |
533 | Phosphorylation | LVAVGVLSGNRNFEG EEEEEEECCCCCCCC | 31.45 | 23312004 | |
572 | Ubiquitination | TIRIDFEKEPLGVNA EEEEEECCCCCCCCC | 65.70 | 21890473 | |
572 | 2-Hydroxyisobutyrylation | TIRIDFEKEPLGVNA EEEEEECCCCCCCCC | 65.70 | - | |
580 | Ubiquitination | EPLGVNAKGQQVFLK CCCCCCCCCCEEEEE | 52.64 | 21890473 | |
587 | Ubiquitination | KGQQVFLKDIWPTRD CCCEEEEECCCCCHH | 35.39 | - | |
610 | Ubiquitination | YVIPGMFKEVYQKIE HCCCCHHHHHHHHHH | 37.06 | 21890473 | |
615 | Ubiquitination | MFKEVYQKIETVNES HHHHHHHHHHHHHHH | 25.48 | 21906983 | |
622 | Phosphorylation | KIETVNESWNALATP HHHHHHHHHHCCCCC | 22.04 | - | |
628 | Phosphorylation | ESWNALATPSDKLFF HHHHCCCCCCCCEEE | 24.95 | 8041788 | |
630 | Phosphorylation | WNALATPSDKLFFWN HHCCCCCCCCEEEEC | 42.92 | 20068231 | |
632 | Ubiquitination | ALATPSDKLFFWNSK CCCCCCCCEEEECCC | 52.08 | 21906983 | |
638 | Phosphorylation | DKLFFWNSKSTYIKS CCEEEECCCCCCCCC | 20.69 | 29514088 | |
639 | Ubiquitination | KLFFWNSKSTYIKSP CEEEECCCCCCCCCC | 43.53 | 21890473 | |
639 | Ubiquitination | KLFFWNSKSTYIKSP CEEEECCCCCCCCCC | 43.53 | 21890473 | |
640 | Phosphorylation | LFFWNSKSTYIKSPP EEEECCCCCCCCCCC | 26.68 | 28857561 | |
644 | Ubiquitination | NSKSTYIKSPPFFEN CCCCCCCCCCCCHHC | 46.63 | 21906983 | |
645 | Phosphorylation | SKSTYIKSPPFFENL CCCCCCCCCCCHHCC | 28.39 | 24275569 | |
702 | Phosphorylation | YLTNRGLTPREFNSY HHHCCCCCHHHCCCC | 24.11 | 24719451 | |
711 | Phosphorylation | REFNSYGSRRGNDAV HHCCCCCCCCCCCCC | 15.57 | 22817900 | |
713 | Methylation | FNSYGSRRGNDAVMA CCCCCCCCCCCCCCC | 50.38 | 81424313 | |
719 | Sulfoxidation | RRGNDAVMARGTFAN CCCCCCCCCCCHHHH | 1.95 | 30846556 | |
721 | Methylation | GNDAVMARGTFANIR CCCCCCCCCHHHHHH | 26.96 | 82797163 | |
736 | Ubiquitination | LLNRFLNKQAPQTIH HHHHHHCCCCCCEEE | 50.40 | 21890473 | |
759 | Phosphorylation | VFDAAERYQQAGLPL HHHHHHHHHHCCCCE | 9.11 | 22817900 | |
772 | Ubiquitination | PLIVLAGKEYGAGSS CEEEECCCCCCCCCC | 42.00 | 21890473 | |
778 | Phosphorylation | GKEYGAGSSRDWAAK CCCCCCCCCCHHHHC | 22.97 | 26437602 | |
785 | Ubiquitination | SSRDWAAKGPFLLGI CCCHHHHCCHHHHCH | 60.41 | 21890473 | |
799 | Phosphorylation | IKAVLAESYERIHRS HHHHHHHHHHHHHHH | 27.04 | 20860994 | |
800 | Phosphorylation | KAVLAESYERIHRSN HHHHHHHHHHHHHHC | 10.75 | 20860994 | |
806 | Phosphorylation | SYERIHRSNLVGMGV HHHHHHHHCCCCCEE | 21.98 | - | |
844 | Ubiquitination | IIIPENLKPQMKVQV EEECCCCCCCEEEEE | 44.80 | 2190698 | |
852 | Ubiquitination | PQMKVQVKLDTGKTF CCEEEEEEECCCCEE | 24.45 | - | |
852 | Acetylation | PQMKVQVKLDTGKTF CCEEEEEEECCCCEE | 24.45 | 25953088 | |
857 | Ubiquitination | QVKLDTGKTFQAVMR EEEECCCCEEEEEEE | 48.54 | - | |
857 | 2-Hydroxyisobutyrylation | QVKLDTGKTFQAVMR EEEECCCCEEEEEEE | 48.54 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ACOC_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ACOC_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FBXL5_HUMAN | FBXL5 | physical | 19762596 | |
A4_HUMAN | APP | physical | 21832049 | |
C10_HUMAN | C12orf57 | physical | 22939629 | |
PYRG1_HUMAN | CTPS1 | physical | 22863883 | |
PSMG1_HUMAN | PSMG1 | physical | 22863883 | |
TXD17_HUMAN | TXNDC17 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...